Skip to main content

8 Result(s)

within A J M Ferreri Remove this filter Hematology Remove this filter

and

  1. No Access

    Article

    Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy

    In diffuse large B-cell lymphoma (DLBCL), the clinical and biological significance of concordant and discordant bone marrow (BM) involvement have not been well investigated. We evaluated 712 de novo DLBCL patient...

    Z Yao, L Deng, Z Y Xu-Monette, G C Manyam, P Jain, A Tzankov, C Visco, G Bhagat… in Leukemia (2018)

  2. No Access

    Article

    Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

    PRDM1/BLIMP-1, a master regulator of plasma-cell differentiation, is frequently inactivated in activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) patients. Little is known about its genetic aberrat...

    Y **a, Z Y Xu-Monette, A Tzankov, X Li, G C Manyam, V Murty, G Bhagat, S Zhang… in Leukemia (2017)

  3. No Access

    Article

    Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium

    Primary testicular diffuse large B-cell lymphoma (PT-DLBCL) is a unique subtype of DLBCL. The impact of rituximab on survival and patterns of treatment failure in PT-DLBCL patient remain controversial. We anal...

    L Deng, Z Y Xu-Monette, S Loghavi, G C Manyam, Y **a, C Visco, J Huh, L Zhang… in Leukemia (2016)

  4. Article

    Erratum: Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

    Correction to: Leukemia (2012) 26, 2103–2113; doi:10.1038/leu.2012.83 Since the publication of this article, the authors have identified an omission in their paper, namely that important Supplementary Data was...

    C Visco, Y Li, Z Y Xu-Monette, R N Miranda, T M Green, Y Li, A Tzankov, W Wen… in Leukemia (2014)

    Download PDF (100 KB) View Article

  5. No Access

    Article

    Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

    Gene expression profiling (GEP) has stratified diffuse large B-cell lymphoma (DLBCL) into molecular subgroups that correspond to different stages of lymphocyte development–namely germinal center B-cell like an...

    C Visco, Y Li, Z Y Xu-Monette, R N Miranda, T M Green, Y Li, A Tzankov, W Wen… in Leukemia (2012)

  6. No Access

    Article

    Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation

    Evidence from certain geographical areas links lymphomas of the ocular adnexa marginal zone B-cell lymphomas (OAMZL) with Chlamydophila psittaci (Cp) infection, suggesting that lymphoma development is dependent u...

    A Dagklis, M Ponzoni, S Govi, M G Cangi, E Pasini, F Charlotte, A Vino… in Leukemia (2012)

  7. No Access

    Article

    Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma

    Recent studies addressing the molecular characteristics of PCNSL, which is defined as malignant B-cell lymphoma with morphological features of DLBCL, have significantly improved our understanding of the pathog...

    M Deckert, A Engert, W Brück, A J M Ferreri, J Finke, G Illerhaus, W Klapper… in Leukemia (2011)

  8. No Access

    Article

    Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma

    The role of 18FDG-PET/CT during follow-up of patients affected by Hodgkin’s lymphoma (HL) in complete remission after treatment is not fully elucidated, since a wide use of 18F fluorodeoxyglucose positron emissio...

    R. Crocchiolo, F. Fallanca, G. Giovacchini, A. J. M. Ferreri… in Annals of Hematology (2009)